Skip to main content
Article thumbnail
Location of Repository

Regulation of S. aureus biofilm formation

By Miranda Johnson

Abstract

S. aureus is a natural commensal of the human host and an opportunistic pathogen that causes a wide range of diseases. Biofilm formation is an important S. aureus virulence determinant. S. aureus colonisation of medical devices and host tissues as a biofilm can impede treatment as genetically and metabolically diverse cells in the different layers of the film can prevent the penetration or activity of the therapeutic agent used. Biofilm formation is a multi-factorial process which can be influenced by many environmental factors. A major environmental stress encountered by bacteria in vivo is severe iron-restriction. However, pathogenic bacteria can use low iron concentrations as a signal to up regulate factors responsible for virulence. This work demonstrates for the first time that S. aureus biofilm formation is iron regulated. It demonstrates that biofilms formed in low iron are dependant on the proteins Eap and Emp which are also iron regulated and are positively regulated by the ferric uptake regulator, Fur. This work has also identified that PNAG, which currently has a controversial role in biofilm formation, was capable of compensating for the loss of Eap and Emp in low iron when it was over expressed, but that wild type levels of PNAG appeared to have a limited role. Nevertheless, the ica operon responsible for the production of PNAG was essential for the expression of Eap and Emp. In addition, Sae, Fur, Agr, SarA and Hfq were shown to all have interlinking roles in the expression of these and other proteins associated with virulence and low iron biofilm formation. The identification of the importance of Eap and Emp in low iron biofilm formation and the regulatory network controlling their expression may have implications on the development of new therapeutic agents essential for the prevention and treatment of S. aureus infection

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/9934

Suggested articles

Citations

  1. (2002). [Biofilms and their significance in medical microbiology],"
  2. (2009). [Diversification of agr locus among Staphylococcus aureus isolated from carriers and from hospital patients with infection syndromes],"
  3. (2000). 6S RNA regulates E. coli RNA polymerase activity,"
  4. (2006). A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms,"
  5. (1999). A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group,"
  6. (2002). A component of innate immunity prevents bacterial biofilm development,"
  7. (2004). A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence,"
  8. (2008). A geographic variant of the Staphylococcus aureus Panton-Valentine leukocidin toxin and the origin of communityassociated methicillin-resistant S. aureus USA300,"
  9. (1995). A homologue to the Escherichia coli alkyl hydroperoxide reductase AhpC is induced by osmotic upshock in Staphylococcus aureus,"
  10. (2000). A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus,"
  11. (2003). A new staphylococcal sigma factor in the conserved gene cassette: functional significance and implication for the evolutionary processes,"
  12. (2002). A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds,"
  13. (1990). A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae,"
  14. (2008). A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections,"
  15. (2005). A simplified model for the steady-state biofilm-activated sludge reactor,"
  16. (2002). A small RNA regulates the expression of genes involved in iron metabolism in Escherichia coli,"
  17. (2008). A systematic review comparing the relative effectiveness of antimicrobialcoated catheters in intensive care units,"
  18. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity,"
  19. (2008). A useful clinical approach to community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections,"
  20. (2002). Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin,"
  21. (1985). Adherence of coagulase-negative staphylococci to plastic Regulation of S. aureus biofilm formation.
  22. (1982). Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces,"
  23. (2008). agr function in clinical Staphylococcus aureus isolates,"
  24. (2008). Agr-mediated dispersal of Staphylococcus aureus biofilms,"
  25. (2003). Alpha-defensins in the gastrointestinal tract,"
  26. (1991). Alpha-toxin of Staphylococcus aureus,"
  27. (2000). Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate,"
  28. (2002). An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis,"
  29. (2006). An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus,"
  30. (2001). Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis,"
  31. (2009). Ancient Photosynthetic Eukaryote Biofilms in an Atacama Desert Coastal Cave," Microb Ecol.
  32. (2003). Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology,"
  33. (2007). Antibacterial surfaces on expanded polytetrafluoroethylene; penicillin attachment,"
  34. (2003). Antimicrobial efficacy of a silver-zeolite matrix coating on stainless steel,"
  35. (2009). Assessing the contribution of heme-iron acquisition to Staphylococcus aureus pneumonia using computed tomography,"
  36. (2007). Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections,"
  37. (2003). Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system,"
  38. (2003). Autoinduction and signal transduction in the regulation of staphylococcal virulence,"
  39. (2008). Bacterial biofilms. Preface,"
  40. (1999). Bacterial fibronectinbinding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells,"
  41. (1997). Bacterial interference caused by autoinducing peptide variants,"
  42. (2003). Bacterial iron homeostasis,"
  43. (1999). Bacterial superantigens induce down-modulation of CC chemokine responsiveness in human monocytes via an alternative chemokine ligand-independent mechanism,"
  44. (2002). Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome,"
  45. (2001). Bap, a Staphylococcus aureus surface protein involved in biofilm formation,"
  46. (2009). Biofilm characteristics of Staphylococcus epidermidis isolates associated with device-related meningitis,"
  47. (2006). Biofilm formation by and accessory gene regulator typing of methicillin-resistant Staphylococcus aureus strains recovered from patients with nosocomial infections,"
  48. Biofilm formation by Staphylococcus epidermidis depends on functional RsbU, an activator of the sigB operon: differential activation mechanisms due to ethanol and salt stress,"
  49. (2005). Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model,"
  50. (2006). Biofilm-associated proteins,"
  51. (2006). Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin,"
  52. Biofilms, the customized microniche,"
  53. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms,"
  54. (2004). Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans,"
  55. (1999). Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen,"
  56. (2004). Calcium inhibits bap-dependent multicellular behavior in Staphylococcus aureus,"
  57. (1999). Campylobacter jejuni contains two fur homologs: characterization of iron-responsive regulation of peroxide stress defense genes by the PerR repressor,"
  58. (1988). Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes,"
  59. (2003). Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus,"
  60. (1998). Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus,"
  61. (1994). Characterization of a Tn551-mutant of Staphylococcus aureus defective in the production of several exoproteins,"
  62. (2003). Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus,"
  63. (2003). Characterization of Staphylococcus aureus enterotoxin L,"
  64. (1999). Characterization of the major superoxide dismutase of Staphylococcus aureus and its role in starvation survival, stress resistance, and pathogenicity,"
  65. (1998). Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin,"
  66. (1996). Characterization of the sar locus and its interaction with agr in Staphylococcus aureus,"
  67. (2005). Characterization of the small untranslated RNA RyhB and its regulon in Vibrio cholerae,"
  68. (1996). Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation,"
  69. (2005). Characterization of Vibrio cholerae RyhB: the RyhB regulon and role of ryhB in biofilm formation,"
  70. (2006). Characterizing the effect of the Staphylococcus aureus virulence factor regulator, SarA, on log-phase mRNA half-lives,"
  71. (2004). Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis,"
  72. (1994). Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus,"
  73. (1994). Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr,"
  74. (1998). Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus,"
  75. (2001). Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community,"
  76. (1998). Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk,"
  77. (2007). Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin,"
  78. (2007). Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcareassociated infections,"
  79. (2008). Community-associated meticillin-resistant Staphylococcus aureus: what are we missing?,"
  80. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection,"
  81. (2007). Complete and SOS-mediated response of Staphylococcus aureus to the antibiotic ciprofloxacin,"
  82. (2002). Conservation, surface exposure, and in vivo expression of the Frp family of iron-regulated cell wall proteins in Staphylococcus aureus,"
  83. (1990). Control of Escherichia coli superoxide dismutase (sodA and sodB) genes by the ferric uptake regulation (fur) locus,"
  84. (1999). Copper resistance & its correlation to multiple drug resistance in Salmonella typhi isolates from south Karnataka,"
  85. (2001). Correlation of Staphylococcus aureus icaADBC genotype and biofilm expression phenotype,"
  86. (2003). Coupled degradation of a small regulatory RNA and its mRNA targets in Escherichia coli,"
  87. (2001). Crystallographic and modeling studies of RNase III suggest a mechanism for double-stranded RNA cleavage,"
  88. (1994). Current Protocols in Molecular Biology.
  89. (2009). Cytotoxicity and genotoxicity of silver nanoparticles in human cells,"
  90. (1998). Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes,"
  91. (2004). Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model,"
  92. (2007). Detection of methicillin resistance in Staphylococcus aureus isolated from pediatric patients: is the cefoxitin disk diffusion test accurate enough?,"
  93. (2006). Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital,"
  94. (1997). Developmental biology of biofilms: implications for treatment and control,"
  95. (2006). Discrete steps in sensing of beta-lactam antibiotics by the BlaR1 protein of the methicillinresistant Staphylococcus aureus bacterium,"
  96. (2006). Distribution of the serine-aspartate repeat protein-encoding sdr genes among nasalcarriage and invasive Staphylococcus aureus strains,"
  97. (2004). Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia,"
  98. (2009). DNA as an adhesin: Bacillus cereus requires extracellular DNA to form biofilms,"
  99. (2006). Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus,"
  100. (2004). Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance,"
  101. (2006). Effects of short interfering RNA against methicillin-resistant Staphylococcus aureus coagulase in vitro and in vivo,"
  102. (2006). Effects of storage time and exogenous protease inhibitors on plasma protein levels,"
  103. (2007). Emergence of an epidemic clone of community-associated methicillin-resistant panton-valentine leucocidinnegative Staphylococcus aureus in cystic fibrosis patient populations,"
  104. (2006). Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections,"
  105. (2007). Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003,"
  106. (2006). Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India,"
  107. (1985). Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types,"
  108. (2003). Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001,"
  109. (2005). Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia,"
  110. (1998). Eubacterial sigma-factors,"
  111. (2003). European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates,"
  112. (1985). Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge,"
  113. (2004). Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin,"
  114. (2005). Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates,"
  115. (1992). Evidence for three different fibrinogen-binding proteins with unique properties from Staphylococcus aureus strain Newman,"
  116. (2009). Experimental discovery of sRNAs in Vibrio cholerae by direct cloning, 5S/tRNA depletion and parallel sequencing,"
  117. (2006). Expression of gamma-hemolysin regulated by sae in Staphylococcus aureus strain Smith 5R,"
  118. (2001). Expression of pls, a gene closely associated with the mecA gene of Regulation of S. aureus biofilm formation.
  119. (2006). Expression of SarX, a negative regulator of agr and exoprotein synthesis, is activated by MgrA in Staphylococcus aureus,"
  120. (2004). Expression of staphylococcal clumping factor A impedes macrophage phagocytosis,"
  121. (2007). Expression of the iron-activated nspA and secY genes in Neisseria meningitidis group B by Fur-dependent and -independent mechanisms,"
  122. (2005). Extracellular carbohydrate-containing polymers of a model biofilm-producing strain, Staphylococcus epidermidis RP62A,"
  123. (2005). Extracellular DNA in single- and multiplespecies unsaturated biofilms,"
  124. (2002). Extracellular DNA required for bacterial biofilm formation,"
  125. (2001). Extracellular fibrinogen-binding protein, Efb, from Staphylococcus aureus blocks platelet aggregation due to its binding to the alpha-chain,"
  126. (1982). Factors that affect the in-vitro activity of cephalosporin antibiotics,"
  127. (2001). Fibronectin-binding protein A of Staphylococcus aureus has multiple, substituting, binding regions that mediate adherence to fibronectin and invasion of endothelial cells,"
  128. (1999). Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1,"
  129. (1999). Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state,"
  130. (1999). Forging a link between biofilms and disease,"
  131. (2006). Functional analysis of luxS in Staphylococcus aureus reveals a role in metabolism but not quorum sensing,"
  132. (2004). Fur functions as an activator and as a repressor of putative virulence genes in Neisseria meningitidis,"
  133. (2000). Fur positive regulation of iron superoxide dismutase in Escherichia coli: functional analysis of the sodB promoter,"
  134. (2000). Fur-independent regulation of iron metabolism by Irr in Bradyrhizobium japonicum,"
  135. (2003). fur-independent regulation of the Pasteurella multocida hbpA gene encoding a haemin-binding protein,"
  136. (2002). Fur-mediated transcriptional and post-transcriptional regulation of FeSOD expression in Escherichia coli,"
  137. Gene expression in Pseudomonas aeruginosa: evidence of iron override effects on quorum sensing and biofilm-specific gene regulation,"
  138. (1992). Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor,"
  139. (2008). Genetic lineages of community-associated methicillin-resistant Staphylococcus aureus in Kuwait hospitals,"
  140. (2009). Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues,"
  141. (2003). Global regulation of Staphylococcus aureus genes by Rot,"
  142. (2002). Global repression of exotoxin synthesis by staphylococcal superantigens,"
  143. (2002). Glycopeptide antibiotic resistance,"
  144. (1999). Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus,"
  145. (2006). Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities,"
  146. (2002). Guidelines for the prevention of intravascular catheter-related infections,"
  147. (2000). Hfq (HF1) stimulates ompA mRNA decay by interfering with ribosome binding,"
  148. (2003). Hfq affects the length and the frequency of short oligo(A) tails at the 3' end of Escherichia coli rpsO mRNAs,"
  149. (2004). Hfq is essential for Vibrio cholerae virulence and downregulates sigma expression,"
  150. (2004). Hfq, a new chaperoning role: binding to messenger RNA determines access for small RNA regulator,"
  151. (1993). High sodium chloride concentrations inhibit staphylococcal enterotoxin C gene (sec) expression at the level of sec mRNA,"
  152. (2009). Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy,"
  153. (2009). Host iron binding proteins acting as niche indicators for Neisseria meningitidis,"
  154. (2001). How superoxide radical damages the cell,"
  155. (1997). Human kininogens regulate thrombin binding to platelets through the glycoprotein Ib-IX-V complex,"
  156. (1991). Human lactoferrin binding in clinical isolates of Staphylococcus aureus,"
  157. (2004). Hydrophobic interactions drive ligand-receptor recognition for activation and inhibition of staphylococcal quorum sensing,"
  158. Hyphal content determines the compression strength of Candida albicans biofilms,"
  159. (2007). ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus,"
  160. (2002). icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis,"
  161. (2000). Identification and characterization of a membrane permease involved in iron-hydroxamate transport in Staphylococcus aureus,"
  162. (2003). Identification and characterization of a new staphylococcal enterotoxin-related putative toxin encoded by two kinds of plasmids,"
  163. (2001). Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus,"
  164. (2003). Identification of a 5-nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA-binding properties of IcaR,"
  165. (2000). Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1,"
  166. (2003). Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity,"
  167. (1998). Identification of a zinc-specific metalloregulatory protein, Zur, controlling zinc transport operons in Bacillus subtilis,"
  168. (2008). Identification of factors contributing to Tcell toxicity of Staphylococcus aureus clinical isolates,"
  169. (2003). Identification of iron-activated and -repressed FurRegulation of S. aureus biofilm formation.
  170. Identification of novel small RNAs using comparative genomics and microarrays,"
  171. (2004). Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus,"
  172. (2004). Identification of tandem duplicate regulatory small RNAs in Pseudomonas aeruginosa involved in iron homeostasis,"
  173. (2007). Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests,"
  174. (2005). Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases,"
  175. (2005). Immune evasion by staphylococci,"
  176. (2009). Immune evasion by Staphylococcus aureus conferred by ironregulated surface determinant protein IsdH,"
  177. (2002). Immunochemical properties of the staphylococcal poly-Nacetylglucosamine surface polysaccharide,"
  178. (2001). Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis,"
  179. (2009). In vitro activity of LK157, a novel tricyclic carbapenem as broad-spectrum {beta}-lactamase inhibitor,"
  180. (1996). In vivo expression of exoprotein synthesis with a Sae mutant of Staphylococcus aureus,"
  181. (2001). In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected],"
  182. (1999). Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides,"
  183. (2001). Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus,"
  184. (1985). Inducible plasmid-mediated copper resistance in Escherichia coli,"
  185. (2006). Induction of expression of hfq by DksA is essential for Shigella flexneri virulence,"
  186. (2004). Infection and immunity
  187. (2005). Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils,"
  188. (2004). Interaction of Bacillus subtilis extracytoplasmic function (ECF) sigma factors with the N-terminal regions of their potential anti-sigma factors,"
  189. (1974). Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes,"
  190. (2003). Interaction of the RNA chaperone Hfq with mRNAs: direct and indirect roles of Hfq in iron metabolism of Escherichia coli,"
  191. (1994). Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation,"
  192. (2009). Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation,"
  193. (1997). Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations,"
  194. (1988). Interference of Staphylococcus aureus lipase with human granulocyte function,"
  195. (2008). International legal options for the control of biofouling on international vessels,"
  196. (2008). Intracellular iron transport and storage: from molecular mechanisms to health implications,"
  197. (2006). Investigations of Rhizobium biofilm formation,"
  198. (2002). Iron acquisition by Gram-positive bacterial pathogens,"
  199. (2005). Iron and fur regulation in Vibrio cholerae and the role of fur in virulence,"
  200. (1978). Iron and infection,"
  201. (2002). Iron deficiency in cystic fibrosis: relationship to lung disease severity and chronic Pseudomonas aeruginosa infection,"
  202. (2005). Iron salts perturb biofilm formation and disrupt existing biofilms of Pseudomonas aeruginosa,"
  203. (1998). Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B,"
  204. (2008). Iron-regulated biofilm formation in Staphylococcus aureus Newman requires ica and the secreted protein Emp,"
  205. (2004). Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme,"
  206. (1998). Iron-responsive gene regulation in a campylobacter jejuni fur mutant,"
  207. (2005). Iron-responsive regulation of biofilm formation in staphylococcus aureus involves fur-dependent and furindependent mechanisms,"
  208. (2005). Iron-responsive regulation of the Helicobacter pylori iron-cofactored superoxide dismutase SodB is mediated by Fur,"
  209. (2004). Iron-source preference of Staphylococcus aureus infections,"
  210. (2006). Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?,"
  211. (2009). IscR controls iron-dependent biofilm formation in Escherichia coli by regulating type I fimbria expression,"
  212. (1977). Isolation and characterization of a plasmid involved with enterotoxin B production in Staphylococcus aureus,"
  213. (2001). Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces,"
  214. (1996). Lack of the extracellular 19-kilodalton fibrinogen-binding protein from Staphylococcus aureus decreases virulence in experimental wound infection,"
  215. (2001). Linezolid resistance in a clinical isolate of Staphylococcus aureus,"
  216. (2007). Localized tufts of fibrils on Staphylococcus epidermidis NCTC 11047 are comprised of the accumulation-associated protein,"
  217. (2001). Loss of clumping factor B fibrinogen binding activity by Staphylococcus aureus involves cessation of transcription, shedding and cleavage by metalloprotease,"
  218. (1984). Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus,"
  219. Membrane-associated redox cycling of copper mediates hydroperoxide toxicity in Escherichia coli,"
  220. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department,"
  221. (1961). Methicillin-resistant staphylococci,"
  222. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility,"
  223. (1995). Microbial biofilms
  224. (2009). Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation,"
  225. (2003). Molecular architecture of the regulatory Locus sae of Staphylococcus aureus and its impact on expression of virulence factors,"
  226. (2007). Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine,"
  227. (2005). Molecular basis of florfenicol-induced increase in adherence of Staphylococcus aureus strain Newman,"
  228. (1992). Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin,"
  229. (1994). Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus,"
  230. (2000). Molecular characterization of the ferric-uptake regulator, fur, from Staphylococcus aureus,"
  231. (1999). Molecular mechanisms of Staphylococcus epidermidis biofilm formation,"
  232. (2000). Molecular pathogenesis of staphylcoccal osteomyelitis,"
  233. (1994). MSCRAMM-mediated adherence of microorganisms to host tissues,"
  234. (2006). Multiple bacterial species reside in chronic wounds: a longitudinal study,"
  235. (2002). Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serineaspartate repeat protein SdrE and protein A,"
  236. (2003). Mutation of sarA in Staphylococcus aureus limits biofilm formation,"
  237. (2006). Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001-2002,"
  238. (2000). Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery,"
  239. (1997). Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks,"
  240. (2009). Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects,"
  241. (1991). Nasal, axillary, and perineal carriage of Staphylococcus aureus among women: identification of strains producing epidermolytic toxin,"
  242. (2009). Necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus: an increasing cause of "mayhem in the lung","
  243. (1997). Negative regulation of mutS and mutH repair gene expression by the Hfq and RpoS global regulators of Escherichia coli K-12,"
  244. (1984). New shuttle vectors for Bacillus subtilis and Escherichia coli which allow rapid detection of inserted fragments,"
  245. (2007). No detectable effect of RNA-binding protein Hfq absence in Staphylococcus aureus,"
  246. (2002). Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains,"
  247. (1990). Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones,"
  248. (2004). Occurrence of copper resistant mutants in the toxic cyanobacteria Microcystis aeruginosa: characterisation and future implications in the use of copper sulphate as algaecide,"
  249. (2003). Occurrence of resistance to antibiotics, metals, and plasmids in clinical strains of Staphylococcus spp,"
  250. (2004). Osteomyelitis,"
  251. (2007). Overcoming resistance to betalactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244,"
  252. (2006). Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children,"
  253. (1992). Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion,"
  254. (2003). Passage of heme-iron across the envelope of Staphylococcus aureus,"
  255. (1983). Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics,"
  256. (2006). Peptidoglycan recognition proteins are a new class of human bactericidal proteins,"
  257. (1998). Peritonitis as a complication of peritoneal dialysis,"
  258. (2005). Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection,"
  259. (2004). Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system,"
  260. (2007). Positive regulation of fur gene expression via direct interaction of fur in a pathogenic bacterium, Vibrio vulnificus,"
  261. (2006). Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment,"
  262. (1984). Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus,"
  263. (2001). Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections,"
  264. (2009). Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) from 14 cities in China," Antimicrob Agents Chemother.
  265. (2003). Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians,"
  266. (1998). Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation,"
  267. (2000). Protein A is the von Willebrand factor binding protein on Staphylococcus aureus,"
  268. (1966). Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin,"
  269. (2009). Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients,"
  270. (1993). Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci,"
  271. (2005). Purpura fulminans due to Staphylococcus aureus,"
  272. (2004). Quantification of virulence-associated gene transcripts in epidemic methicillin resistant Staphylococcus aureus by real-time PCR,"
  273. (2000). Quorum sensing and starvation: signals for entry into stationary phase,"
  274. (2008). Quorum sensing in staphylococci,"
  275. (2004). Quorum sensing in Staphylococcus aureus biofilms,"
  276. (2002). Rapid reduction of Staphylococcus aureus populations on stainless steel surfaces by zeolite ceramic coatings containing silver and zinc ions,"
  277. (1987). Rapid screening method for detection of bacterial mutants with altered adhesion abilities,"
  278. (2001). Rebinding of extracellular adherence protein Eap to Staphylococcus aureus can occur through a surface-bound neutral phosphatase,"
  279. (1998). Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci,"
  280. (1992). Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr,"
  281. (2000). Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori,"
  282. (2009). Regulation of S. aureus biofilm formation.
  283. (2006). Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis,"
  284. (2001). Regulation of virulence determinants in Staphylococcus aureus,"
  285. (2004). Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus,"
  286. (2008). Regulatory organization of the staphylococcal sae locus,"
  287. (1992). Relationship between Desiccation and Exopolysaccharide Production in a Soil Pseudomonas sp,"
  288. (2002). Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease,"
  289. (2006). Remodelling of the Escherichia coli outer membrane by two small regulatory RNAs,"
  290. (2008). Repression of hla by rot is dependent on sae in Staphylococcus aureus,"
  291. (2001). Riddle of biofilm resistance,"
  292. (2004). Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus noncarriers,"
  293. (2008). RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus,"
  294. (2004). Role of biofilm-associated protein bap in the pathogenesis of bovine Staphylococcus aureus,"
  295. (2002). Role of electrostatic interactions in cohesion of bacterial biofilms,"
  296. (1978). Role of iron in bacterial infection,"
  297. (1993). Role of iron in regulation of virulence genes,"
  298. (1998). Role of SarA in virulence determinant production and environmental signal transduction in Staphylococcus aureus,"
  299. (2004). Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore,"
  300. (2005). Role of Staphylococcus aureus global regulators sae and sigmaB in virulence gene expression during device-related infection,"
  301. (2005). Role of the distal sarA promoters in SarA expression in Staphylococcus aureus,"
  302. (2008). Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial,"
  303. (2005). sae is essential for expression of the staphylococcal adhesins Eap and Emp,"
  304. (2003). SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus,"
  305. (2009). sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus,"
  306. (2008). SarA of Staphylococcus aureus binds to the sarA promoter to regulate gene expression,"
  307. (1999). SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sardependent gene regulation,"
  308. (2001). SarS, a SarA homolog repressible by agr, is an activator of protein A synthesis in Staphylococcus aureus,"
  309. (2001). SarT, a repressor of alphahemolysin in Staphylococcus aureus,"
  310. (2003). sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus,"
  311. (2008). SarZ is a key regulator of biofilm formation and virulence in Staphylococcus epidermidis,"
  312. (1987). Serotyping and electron
  313. (1998). Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis,"
  314. Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins,"
  315. (2004). Sigma factor B and RsbU are required for virulence in Staphylococcus aureus-induced arthritis and sepsis,"
  316. (2001). Sigma(B) activity depends on RsbU in Staphylococcus aureus,"
  317. (2005). siRNA therapeutics: big potential from small RNAs,"
  318. (1998). SirR, a novel iron-dependent repressor in Staphylococcus epidermidis,"
  319. (2005). Small RNA genes expressed from Staphylococcus aureus genomic and pathogenicity islands with specific expression among pathogenic strains,"
  320. (2004). Standard nomenclature for the superantigens expressed by Staphylococcus,"
  321. (2007). Staphylococcal chromosomal cassette mec type I, spa type, and expression of Pls are determinants of reduced cellular invasiveness of methicillinresistant Staphylococcus aureus isolates,"
  322. (1952). Staphylococcal coagulase; mode of action and antigenicity,"
  323. (1985). Staphylococcal enterotoxin A is encoded by phage,"
  324. (1978). Staphylococcal enterotoxin A: a chromosomal gene product,"
  325. (2000). Staphylococcal enterotoxins,"
  326. (2005). Staphylococcal innate immune evasion,"
  327. (2008). Staphylococcus : molecular genetics
  328. (2002). Staphylococcus and biofilms,"
  329. (2004). Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region,"
  330. (2003). Staphylococcus aureus and food poisoning,"
  331. (2001). Staphylococcus aureus and Staphylococcus epidermidis peptide pheromones produced by the accessory gene regulator agr system,"
  332. (2008). Staphylococcus aureus antigens and challenges in vaccine development,"
  333. Staphylococcus aureus CcpA affects biofilm formation,"
  334. (2006). Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance,"
  335. (2005). Staphylococcus aureus develops an alternative, ica-independent biofilm in the absence of the arlRS two-component system,"
  336. (2005). Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity,"
  337. (1995). Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains,"
  338. (1998). Staphylococcus aureus infections,"
  339. (2008). Staphylococcus aureus nasal colonization in HIV outpatients: Persistent or transient?,"
  340. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia,"
  341. (2007). Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases,"
  342. (2004). Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1,"
  343. (2007). Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands,"
  344. (2009). Staphylococcus aureus Rbf activates biofilm formation in vitro and promotes virulence in a murine foreign body infection model,"
  345. (2006). Staphylococcus aureus redirects central metabolism to increase iron availability,"
  346. (1998). Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model,"
  347. (2005). Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence,"
  348. (2009). Staphylococcus aureus: new evidence for intracellular persistence,"
  349. (2004). Staphylococcus aureus: superbug, super genome?,"
  350. (2002). Staphylococcus epidermidis infections,"
  351. (2006). Staphylococcus quorum sensing in biofilm formation and infection,"
  352. (1990). Staphyloferrin A: a structurally new siderophore from staphylococci,"
  353. (2009). stress induces a global stress response and represses sae and agr expression and biofilm formation in Staphylococcus aureus,"
  354. (2002). Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus,"
  355. (2001). Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides,"
  356. (2003). Studies on the expression of regulatory locus sae in Staphylococcus aureus,"
  357. (2003). Sub-lethal effects of a copper sulfate fungicide on development and reproduction in three coccinellid species,"
  358. (2002). Subunit composition of a bicomponent toxin: staphylococcal leukocidin forms an octameric transmembrane pore,"
  359. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis,"
  360. (1987). Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity,"
  361. (1978). Superoxide-dependent formation of hydroxyl radicals in the presence of iron chelates: is it a mechanism for hydroxyl radical production in biochemical systems?,"
  362. (1995). Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family,"
  363. (2005). Tackling mastitis in dairy cows,"
  364. (2002). tcrB, a gene conferring transferable copper resistance in Enterococcus faecium: occurrence, transferability, and linkage to macrolide and glycopeptide resistance,"
  365. (2009). Telavancin: a new lipoglycopeptide for Gram-positive infections,"
  366. (2008). The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in-vitro study,"
  367. (1996). The biochemistry and genetics of capsular polysaccharide production in bacteria,"
  368. (2007). The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus,"
  369. (2000). The collagen-binding adhesin is a virulence factor in Staphylococcus aureus keratitis,"
  370. (2005). The crystal structures of EAP domains from Staphylococcus aureus reveal an unexpected homology to bacterial superantigens,"
  371. (1997). The effects of adherence to silicone surfaces on antibiotic susceptibility in Staphylococcus aureus,"
  372. (1992). The effects of magnesium, calcium, EDTA, and pH on the in vitro adhesion of Staphylococcus epidermidis to plastic,"
  373. (2001). The Fur repressor controls transcription of iron-activated and -repressed genes in Helicobacter pylori,"
  374. (2005). The Hfq homolog in Legionella pneumophila demonstrates regulation by LetA and RpoS and interacts with the global regulator CsrA,"
  375. (2009). The Hfq-dependent small noncoding RNA NrrF directly mediates Furdependent positive regulation of succinate dehydrogenase in Neisseria meningitidis,"
  376. (2000). The immune system (Garland,
  377. (2007). The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?,"
  378. (2006). The innate immune modulators staphylococcal complement inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located on beta-hemolysin-converting bacteriophages,"
  379. (1996). The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis,"
  380. (2001). The intercellular adhesin locus ica is present in clinical isolates of Staphylococcus aureus from bacteremic patients with infected and uninfected prosthetic joints,"
  381. (1974). The involvement of lactoferrin in the hyposideremia of acute inflammation,"
  382. (2005). The leukocidin pore: evidence for an octamer with four LukF subunits and four LukS subunits alternating around a central axis,"
  383. (1996). The molecular architecture of the sar locus in Staphylococcus aureus,"
  384. (1997). The molecular basis of pathogenicity,
  385. (2007). The molecular evolution of methicillin-resistant Staphylococcus aureus,"
  386. (2004). The N-terminal A domain of fibronectin-binding proteins A and B promotes adhesion of Staphylococcus aureus to elastin,"
  387. (2007). The RNA chaperone Hfq is essential for the virulence of Salmonella typhimurium,"
  388. (2007). The role of Staphylococcus aureus surface protein SasG in adherence and biofilm formation,"
  389. (1997). The sae locus of Staphylococcus aureus controls exoprotein synthesis at the transcriptional level,"
  390. (1999). The sae locus of Staphylococcus aureus encodes a two-component regulatory system,"
  391. (2008). The SarA protein family of Staphylococcus aureus,"
  392. The Staphyloccous aureus Eap protein activates expression of proinflammatory cytokines,"
  393. (2004). The staphylococcal ferritins are differentially regulated in response to iron and manganese and via PerR and Fur,"
  394. (2003). The staphylococcal saeRS system coordinates environmental signals with agr quorum sensing,"
  395. (1997). The staphylococci in human disease (Churchill Livingstone,
  396. (2000). The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance,"
  397. (2009). The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation,"
  398. (2002). The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses,"
  399. (2003). The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells,"
  400. (2008). The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals,"
  401. (2001). Toxic shock syndrome and bacterial superantigens: an update,"
  402. (2003). Transcriptional profiling of gene expression in response to glucose in Bacillus subtilis: regulation of the central metabolic pathways,"
  403. (1998). Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus,"
  404. (1985). Turgor-controlled K+ fluxes and their pathways in Escherichia coli,"
  405. (1983). Turnover in the transferrin iron pool during the hypoferremic phase of experimental Neisseria meningitidis infection in mice,"
  406. (1991). Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene,"
  407. (1994). Two genetically-distinct and differentially-regulated aconitases (AcnA and AcnB) in Escherichia coli,"
  408. (2007). Use of peptide-major histocompatibility complex tetramer technology to study interactions between Staphylococcus aureus proteins and human cells,"
  409. (2009). VanA-type Staphylococcus aureus VRSA-7 is Partially Dependent on Vancomycin for Growth," Antimicrob Agents Chemother.
  410. (2000). Vancomycin and oxacillin synergy for methicillin-resistant staphylococci,"
  411. (2008). Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006,"
  412. Variation in the expression of cell envelope proteins of coagulase-negative staphylococci cultured under iron-restricted conditions in human peritoneal dialysate,"
  413. (1999). Virulence gene regulation by peptides in staphylococci and other Gram-positive bacteria,"
  414. (2001). Whole genome sequencing of meticillin-resistant Staphylococcus aureus,"
  415. (2001). zur: a Zn(2+)-responsive regulatory element of Staphylococcus aureus,"

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.